Listed by the USPTO as GILL, RACHEL B
Tech Center 1600 • Art Units: 1641 1645 1648 1671
This examiner grants 65% of resolved cases
GILL, RACHEL B is assigned to Technology Center 1600 and Art Unit 1641. The record contains 882 resolved cases, with an allowance rate of 65.4% and a median of 913 days to allowance. The interview lift is 28.8%, indicating a meaningful positive association between interviews and allowance outcomes.
The principal companies are ModernaTX Inc., Flagship Pioneering Inc., and Arizona Board of Regents on Behalf of Arizona State University. The leading firms are FISH & RICHARDSON P.C. (TC), QUARLES & BRADY LLP, and Bayramoglu Law Offices LLC. The data supports combining substantive biotechnology analysis with planned examiner discussions. The allowance rate provides a useful outcome reference, while the median timeline should inform prosecution budgets and portfolio sequencing. The company affiliations suggest matters involving therapeutics, platform technologies, and university-originated inventions.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18030465 | DETECTION OF ACE2 IgM AUTOANTIBODIES AS MARKERS OF SEVERITY AND MECHANISM IN COVID19 PATIENTS | Non-Final OA | The Johns Hopkins University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy65.4% of resolved applications examined by Rachel B Gill were allowed (882 resolved cases), compared with 45.2% across Art Unit 1641 over the last five years.
This examiner's interview lift is +28.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Rachel B Gill took 913 days on average from filing to allowance.
Rachel B Gill examines applications in Art Unit 1641 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
